OUR TEAM

Development

Amit Kohli - Chief Executive Officer

Former COO of Pharnext, a Euronext listed phase 3 neurology biotech.

25+ years of Multifunctional experience – Finance, Marketing, Sales, Manufacturing, R&D in Pharma/ MedTech and Clinical Diagnostics.

GM International Eurofins, Regional Business Director EMA Becton Dickinson, Global Marketing Director, Sanofi.

Carol MacLean PhD, VP, Clinical Operations

Clinical research professional with over 25 years of experience. Strong skills in clinical programme management having worked for Quintiles, Syntex, and Ardana Biosciences. International experience from time spent working in South Africa, Australia, and Austria

Tim Clayton PhD, Director of CMC

Over 30 years of experience in drug development and manufacturing. Experience includes Head of Biotechnology product development; process development; facilities design, build and start-up; regulatory support; technology transfer; MS&T; manufacturing. Specialist in biotechnology products (peptides, interferons, antibodies, other proteins, subunit and DNA vaccines, gene therapy). Commercial products worked with include Wellferon, Rebif, Campath, and Erbitux.

Guy Poland VetMB, Head of Innovation and IP

Cambridge graduate in Zoology and Veterinary Medicine. Ten years of clinical veterinary practice. Over three years at Antev

Dr François Boutignon – Pharmaceutical development consultant

After a post-doc in Oxford, François joined Europeptides where he became VP of R&D. Here, François worked on several long-acting peptides. François co-founded APTYS Pharmaceuticals in 2002